Development of Parkinson's disease biomarkers

Please use this identifier to cite or link to this item: https://doi.org/10.1586/ern.10.73

Title:	Development of Parkinson's disease biomarkers
Authors:	Prakash, K.M. Tan, E.-K.
Keywords:	biomarkers genomic motor neurochemical neuroimaging non-motor Parkinson's disease
Issue Date:	Dec-2010
Citation:	Prakash, K.M., Tan, E.-K. (2010-12). Development of Parkinson's disease biomarkers. Expert Review of Neurotherapeutics 10 (12) : 1811-1825. ScholarBank@NUS Repository. https://doi.org/10.1586/ern.10.73
Abstract:	Parkinson's disease (PD) is the most common neurodegenerative movement disorder, affecting over 6 million people worldwide. It is anticipated that the number of affected individuals may increase significantly in the most populous nations by 2030. During the past 20 years, much progress has been made in identifying and assessing various potential clinical, biochemical, imaging and genetic biomarkers for PD. Despite the wealth of information, development of a validated biomarker for PD is still ongoing. It is hoped that reliable and well-validated biomarkers will provide critical clues to assist in the diagnosis and management of Parkinson's disease patients in the near future. © 2010 Expert Reviews Ltd.
Source Title:	Expert Review of Neurotherapeutics
URI:	http://scholarbank.nus.edu.sg/handle/10635/110698
ISSN:	14737175
DOI:	10.1586/ern.10.73
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check